[first round notice] 2018 China Pharmaceutical R & D Innovation Summit and the list of top 100 pharmaceutical companies in R & D strength

Click the picture to sign up for "2018 China Pharmaceutical R & D Innovation Summit" [invitation letter] in the early stage of reform and opening up, China's pharmaceutical development was very difficult, but in years of hard work, now there is a new pattern In June 2017, China food and Drug Administration officially joined the ICH and chemical drug registration and classification reform to change three types of new drugs into generic drugs The promotion of generic drug consistency evaluation of oral solid preparations is difficult, the injection consistency evaluation is about to be carried out, and new drug registration management measures are about to be introduced Under the background of this era, how do pharmaceutical companies develop generic drugs and develop high-level generic drugs? How to imitate the level, technology and benefit? It's worth our in-depth discussion! This conference will focus on the theme of "research and development of generic drugs in the new era", gather top experts and scholars in the domestic pharmaceutical industry, interpret national policies on the spot with more accurate innovation, and help the new development of generic drugs; dispel the fog for the industry with more comprehensive technology discussion; and guide the strategy for the enterprise with more ingenious planning and analysis This conference will solemnly release the "2018 China Pharmaceutical R & D strength ranking" (the third - Top 100 pharmaceutical enterprises' R & D strength ranking), including the top five lists: general list, Chinese medicine list, chemical medicine list, biological medicine list and brand list, to arouse the enthusiasm of domestic pharmaceutical R & D innovation with the greatest sincerity Here, we sincerely invite you to attend the meeting! 1、 Focusing on the top 100 R & D strength list of 2018 pharmaceutical enterprises, release the interpretation of 2018 China's R & D strength list, 2018 China's comprehensive R & D strength list, release of 2018 China's traditional Chinese medicine R & D strength list and award ceremony, release and award ceremony of 2018 China's chemical R & D strength list Release and awarding ceremony of 2018 China Bio pharmaceutical R & D strength ranking and awarding ceremony of 2018 China Pharmaceutical R & D strength brand ranking and awarding ceremony of strategic partner awarding ceremony for pharmaceutical enterprises: Chairman and general manager of pharmaceutical production enterprises, chairman and general manager of pharmaceutical marketing, middle and senior R & D and management personnel, registrants, BD Scientific research institutes: middle and senior managers, researchers, investment and financing institutions: pharmaceutical industry analysts, M & A experts, consultants, pharmaceutical universities: management, teaching, researchers [guidance unit] China Pharmaceutical University, Chongqing Economic and Information Commission [sponsor] pharmaceutical intelligence network, China Pharmacy magazine [organizer] Pharmaceutical intelligence elite club [CO organizer] Southwest University, more organizations to gather.. [support unit] Chongqing Nan'an District People's government, Chongqing pharmaceutical industry association, more organizations to gather.. [media support] Chongqing daily, Chongqing TV station, Xinhua news agency, Chongqing business daily, Chongqing Evening News, Chongqing Morning News, pharmaceutical progress, China Pharmaceutical guide, Chinese pharmacy, tongfreehand, Hualong health network, biological exploration, gene Valley, shell society, Chinese medicine big variety alliance, pharmaceutical research, artery network, pharmaceutical information new drug development, Sina medicine, Xinkangjie, Bio Valley, health idea ihealth, ilanbo The conference fee of "note: ● those who sign up before April 30 can enjoy the price of" early bird ticket ", including 50 media such as man medical network, health circle, WANYING society, clinical trial network of drugs, DIA, China Medical Science and Technology Press, convergence of South medicine, new drug collection, Dayu network, Sohu network, electronic journal of translational medicine, etc; ● in order to ensure the smooth holding of the conference, the conference will not accept the on-site payment; ● payment method: the application fee will be received by bank wire transfer and post office remittance; ● payment bank: Account Name: Chongqing Kangzhou big data Co., Ltd account number: 31000301191000096622 account bank: Chongqing Nan'an Chayuan branch of industrial and Commercial Bank of China III conference consultation This article is the first round of notification for the 2018 China Pharmaceutical Research and Development Summit The follow-up notice will be released at www.yaozh.com and ID:yaozh008 official account Please pay close attention to this.